Cargando…

Association between renal-limited vasculitis and relapse of antineutrophil cytoplasmic antibody-associated vasculitis: A single-center retrospective cohort study in Japan

BACKGROUND: Several previous studies have evaluated the predictors of relapse in antineutrophil cytoplasmic antibody-associated vasculitis. Nonetheless, the association between renal-limited vasculitis and relapse has not been evaluated. OBJECTIVE: To assess the association between renal-limited vas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamaguchi, Makoto, Ito, Mayumi, Sugiyama, Hirokazu, Iwagaitsu, Shiho, Nobata, Hironobu, Kinashi, Hiroshi, Katsuno, Takayuki, Ando, Masahiko, Kubo, Yoko, Banno, Shogo, Ito, Yasuhiko, Ishimoto, Takuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522015/ https://www.ncbi.nlm.nih.gov/pubmed/36174007 http://dx.doi.org/10.1371/journal.pone.0274483

Ejemplares similares

Association between sinusitis and relapse and changes in the myeloperoxidase–antineutrophil cytoplasmic antibody in microscopic polyangiitis
por: Tanaka, Hiroya, et al.
Publicado: (2020)

Oral candidiasis is a significant predictor of subsequent severe infections during immunosuppressive therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Yamaguchi, Makoto, et al.
Publicado: (2019)

Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5
por: Ito, Mayumi, et al.
Publicado: (2021)

Association between body mass index and severe infection in older adults with microscopic polyangiitis: a retrospective cohort in Japan
por: Sugiyama, Hirokazu, et al.
Publicado: (2021)

Association of alcohol consumption with the incidence of proteinuria and chronic kidney disease: a retrospective cohort study in Japan
por: Tanaka, Akio, et al.
Publicado: (2022)

Relationship between doses of antihypertensive drugs and left ventricular mass index changes in hemodialysis patients in a Japanese cohort
por: Kitamura, Fumiya, et al.
Publicado: (2021)

Case report: Thrombotic microangiopathy concomitant with macrophage activation syndrome in systemic lupus erythematosus refractory to conventional treatment successfully treated with eculizumab
por: Yamaguchi, Makoto, et al.
Publicado: (2023)

Lymphopenia is a risk factor for severe infections in older patients with microscopic polyangiitis: a retrospective cohort study in Japan
por: Yamaguchi, Makoto, et al.
Publicado: (2023)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
por: Mizaki, Tomoko, et al.
Publicado: (2023)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
por: Shikha, Deep, et al.
Publicado: (2015)

Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Golemati, Christina V., et al.
Publicado: (2017)

The role of mycophenolate in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis
por: Koukoulaki, Maria, et al.
Publicado: (2019)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
por: Li, Weiran, et al.
Publicado: (2021)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
por: Kim, Yoon Kook, et al.
Publicado: (2021)

Comparison of lung microbiota between antineutrophil cytoplasmic antibody-associated vasculitis and sarcoidosis
por: Fukui, Shoichi, et al.
Publicado: (2020)

Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis after COVID-19 Vaccination
por: Okuda, Saki, et al.
Publicado: (2021)

Serum interleukin-16 significantly correlates with the Vasculitis Damage Index in antineutrophil cytoplasmic antibody-associated vasculitis
por: Yoon, Taejun, et al.
Publicado: (2020)

Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Ohashi, Keiji, et al.
Publicado: (2017)

Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Geetha, Duvuru, et al.
Publicado: (2018)

Propylthiouracil-induced Otitis Media with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Tanaka, Rika, et al.
Publicado: (2018)

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndrome
por: Aeddula, Narothama Reddy, et al.
Publicado: (2018)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review
por: Choi, Chan-Bum, et al.
Publicado: (2019)

Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Morishita, Michiko, et al.
Publicado: (2017)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
por: Felzer, Jamie R., et al.
Publicado: (2021)

Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis
por: Casal Moura, Marta, et al.
Publicado: (2021)

Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
por: Tran, John Chuan Nguyen, et al.
Publicado: (2022)

Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis
por: Alba, Marco A., et al.
Publicado: (2022)

Acute Respiratory Failure as Primary Manifestation of Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis
por: Sourla, Evdokia, et al.
Publicado: (2014)

Caveolin-1 Single Nucleotide Polymorphism in Antineutrophil Cytoplasmic Antibody Associated Vasculitis
por: Chand, Sourabh, et al.
Publicado: (2013)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
por: Moog, Philipp, et al.
Publicado: (2015)

HLA-B52-positive Aortitis with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Karino, Kohei, et al.
Publicado: (2016)

Aortic Aneurysm as a Complication of Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis
por: Satomura, Atsushi, et al.
Publicado: (2017)

Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis
por: Morishita, Michiko, et al.
Publicado: (2019)

Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
por: Arman, Farid, et al.
Publicado: (2018)

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019)

Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody‐associated vasculitis
por: Lee, Lucy Eunju, et al.
Publicado: (2021)

Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Netherlands
por: Dirikgil, Ebru, et al.
Publicado: (2021)

Predictors of Mortality in Critically Ill Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Zhang, Yuqi, et al.
Publicado: (2021)

Tofacitinib-Induced Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis With Crescentic Glomerulonephritis
por: Asemota, Uyioghosa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ekcqhtun7h3cg9ss9ucpqns31c